http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CO-6251249-A2
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2c5ab150a422f91611f9027414415693 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_382ccfc2ebebcaee15aa7cda4cee86bc |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-445 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4709 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-445 |
filingDate | 2009-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_93cf8a55fc801d6e3e4827d0e7d754f8 |
publicationDate | 2011-02-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CO-6251249-A2 |
titleOfInvention | A MEDICINAL PRODUCT THAT INCLUDES A DERIVATIVE A CARBOSTIRILE DERIVATIVE AND DONEPEZILO TO TREAT ALZHEIMER'S DISEASE |
abstract | 1. A medicament for treating Alzheimer's disease comprising as active components a carbostiryl derivative of the general formula: wherein A is a lower alkylene group, R is a cycloalkyl group, the link between positions 3 and 4 of the carbostiryl skeleton it is a single bond or a double bond, or one of its salts; and donepezil or one of its salts. 2. The medicament according to claim 1, further characterized in that the carbostiryl derivative is 6- [4- (1-cyclohexyl-1H-tetrazol-5-yl) butoxy] -3 , 4-dihydrocarbostiryl or one of its salts. 3. The medicament according to claim 1 or 2, further characterized in that the donepezil salt is donepezil hydrochloride. 4. The use of carbostiril derivative or a salt as set forth in claim 1 or 2, and donepezil or one of its salts for the preparation of a medicament for treating Alzheimer's disease. 5. The use as claimed in claim 4, wherein the donepezil salt is donepezil hydrochloride. 6. A method for treating Alzheimer's disease comprising administering an effective amount of the carbostiryl derivative or one of its salts set forth in claim 1 or 2, and donepezil or one of its salts to a patient in need of said treatment.7 The method according to claim 6, further characterized in that the donepezil salt is donepezil hydrochloride. |
priorityDate | 2007-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 21.